1.7207
price up icon0.58%   0.0107
 
loading

Erasca Inc Azioni (ERAS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
7.00%
38.12
35.63 35.71 37.24 67.78
Operating Income/Loss
7.00%
-38.12
-35.63 -35.71 -37.24 -67.78
Nonoperating Income/Loss
8.90%
4.249
4.664 3.48 6.042 4.581
Income/Loss From Continuing Operations Before Tax
9.40%
-33.88
-30.97 -32.23 -31.20 -63.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.40%
-33.88
-30.97 -32.23 -31.20 -63.20
Net Income/Loss
9.40%
-33.88
-30.97 -32.23 -31.20 -63.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
283.36
283.26 16.46 282.38 217.81
Diluted Average Shares
0.03%
283.36
283.26 16.46 282.38 217.81
Basic Earnings Per Share
9.09%
-0.12
-0.11 -0.09 -0.11 -0.29
Diluted Earnings Per Share
9.09%
-0.12
-0.11 -0.09 -0.11 -0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.72
price up icon 0.67%
$84.72
price up icon 1.04%
$28.04
price down icon 0.74%
$98.96
price up icon 0.18%
$144.02
price down icon 0.42%
biotechnology ONC
$332.06
price up icon 1.52%
Capitalizzazione:     |  Volume (24 ore):